| Dermatitis |
1 |
1 |
| Atopic Dermatitis |
0 |
0.99 |
| Pruritus |
0 |
0.66 |
| Herpes Zoster |
0 |
0.6 |
| Acne |
0 |
0.33 |
| Eczema |
0 |
0.33 |
| Patient Safety |
0 |
0.28 |
| Vaccines |
0 |
0.21 |
| Revenue and Practice Management |
0 |
0.18 |
| Rheumatoid Arthritis |
0 |
0.15 |
| Adverse Effects |
0 |
0.11 |
| Alopecia Areata |
0 |
0.11 |
| Arthritis |
0 |
0.11 |
| Canada |
0 |
0.11 |
| Cyclosporine |
0 |
0.11 |
| Financial Reimbursement |
0 |
0.11 |
| Herpes Zoster Vaccine |
0 |
0.11 |
| Hospital |
0 |
0.11 |
| LDL Cholesterol |
0 |
0.11 |
| Pigmentation |
0 |
0.11 |
| Scar |
0 |
0.11 |
| Severity Index |
0 |
0.11 |
| Steroids |
0 |
0.11 |
| Alopecia |
0 |
0.1 |
| Cardiovascular Risk Management |
0 |
0.1 |
| Inflammatory Bowel Disease |
0 |
0.1 |
| Lipids Management |
0 |
0.1 |
| Skin and Soft Tissue Infection |
0 |
0.1 |